Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

Thompson Coon JS., Liu Z., Hoyle M., Rogers G., Green C., Moxham T., Welch K., Stein K.

DOI

10.1038/sj.bjc.6605447

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2010-01-01T00:00:00+00:00

Volume

102

Pages

234 - 235

Total pages

1

Permalink More information Close